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Background: DNA methylation (5mC) plays important roles in epigenetic regulation of genome function. Recently,
TET hydroxylases have been found to oxidise 5mC to hydroxymethylcytosine (5hmC), formylcytosine (5fC) and
carboxylcytosine (5caC) in DNA. These derivatives have a role in demethylation of DNA but in addition may have
epigenetic signaling functions in their own right. A recent study identified proteins which showed preferential
binding to 5-methylcytosine (5mC) and its oxidised forms, where readers for 5mC and 5hmC showed little overlap,
and proteins bound to further oxidation forms were enriched for repair proteins and transcription regulators. We
extend this study by using promoter sequences as baits and compare protein binding patterns to unmodified or
modified cytosine using DNA from mouse embryonic stem cell extracts.
Results: We compared protein enrichments from two DNA probes with different CpG composition and show that,
whereas some of the enriched proteins show specificity to cytosine modifications, others are selective for both
modification and target sequences. Only a few proteins were identified with a preference for 5hmC (such as RPL26,
PRP8 and the DNA mismatch repair protein MHS6), but proteins with a strong preference for 5fC were more numerous,
including transcriptional regulators (FOXK1, FOXK2, FOXP1, FOXP4 and FOXI3), DNA repair factors (TDG and MPG) and
chromatin regulators (EHMT1, L3MBTL2 and all components of the NuRD complex).
Conclusions: Our screen has identified novel proteins that bind to 5fC in genomic sequences with different CpG compo-
sition and suggests they regulate transcription and chromatin, hence opening up functional investigations of 5fC readers.Background
Levels of 5hmC in DNA (and where known 5fC and
5caC) vary between different mammalian tissues and are
highest in ES cells and neural tissues [1-5]. In situations
where oxidative derivatives of 5mC are implicated in
demethylation of DNA, such as in pluripotent stem
cells, early embryos and germ cells, there may be rapid
turnover of these modifications through a combination of
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stated.TDG, and potentially deamination or decarboxylation [6-8].
In other tissues, especially those with non-dividing cells
such as neural tissues, the modifications could potentially
be more stable and might thus be used as epigenetic signals
for genome function [9-11]. A variety of proteins that bind
to histone modifications or to methylated DNA (methyl
binding domain proteins (MBDs)) have been described and
have a role in interpreting these epigenetic signals for the
regulation of transcription, replication, DNA repair or other
functions of the genome [12-14]. Recently, MBD3 and
MECP2 have been shown to be able to bind 5hmC (MBD3
weakly so) in addition to 5mC, opening up the possibility
that these proteins may also be able to interpret the 5hmC
signal, for example, in the regulation of transcription or
chromatin [15,16]. A recently published unbiased screenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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specific binding to 5mC and its oxidised forms but the
use of a single DNA probe overlooks the possibility that
proteins in a cellular context might have a combined pref-
erence for both DNA modification and sequence context.
Indeed some of the proteins identified as specific for a
DNA modification are cell-type specific, suggesting a
complex protein interaction network operating in modu-
lating the intrinsic ability to bind to DNA modifications.
Results and discussion
We established a proteomics screen for C, 5mC, 5hmC or
5fC binding proteins based on modifications of published
protocols [17]. Briefly, PCR probes were made correspond-
ing to the promoter regions of the Pax6 and Fgf15 genes
(relative position to the gene is shown in Figure 1c
and 1d). Both of these genomic regions are enriched for
5hmC in mESCs, and their corresponding gene expression
is associated with changes in the relative levels of 5mC/
5hmC in control relative to Tet1 siRNA-treated cells [18].
Modified cytosines were incorporated during PCR and the
probes were then incubated with nuclear protein extracts
from mESCs (E14 ES cells cultured in Serum/LIF condi-
tions). Proteins which bound to the probes were eluted
and identified by mass spectrometry (Figure 1a and full
table in Additional file 1). We initially verified whether the
screen was able to enrich the previously known 5mC/
5hmC binder NP95/UHRF1 [19]. Indeed the western blot
in Figure 1b shows specific binding of the protein to
both modifications. Our mass spectrometry results also
confirmed the recently identified proteins specifically
binding to C (KDM2B, CXXC5, BCOR) and 5mC (RFX1,
MBD4) (Additional file 1 and [11]).
Having established a screen that was robust and identi-
fied known binders of both 5mC and 5hmC, we systemat-
ically evaluated all binding proteins and included 5fC
modified targets in the screen (Additional file 1, Figure 1c
and d, Figures 2 and 3). Pull-downs were performed in
triplicate for each DNA modification with both Pax6 and
Fgf15 probes, and resulting values were analysed using a
non-parametric Kruskal-Wallis ANOVA with a threshold
sufficient to identify proteins where the replicates for one
modification were consistently the most enriched against
a random set of enrichments in the other pull-downs. The
Venn diagrams in Figure 1c and 1d include only proteins
with significant enrichment and show binding distribution
to differentially modified probes. A detailed representation
of relative binding of proteins to each modification in each
target sequence is shown in Figures 2a and 3. Heatmaps
were generated by unsupervised hierarchical clustering of
the mass spectral counts for each protein (horizontal lines)
binding to each modification in three replicate pull-downs,
normalised by row mean subtraction. Protein enrichment is
indicated in red (highly enriched) to green (under-enrichedrelative to mean). Some of the candidate proteins are
highlighted on the right side of the heatmaps and the
full list is shown in Additional file 2.
Of interest were proteins that bound only to unmodified
C, such as BEND3, USF1, USF2, CXXC5 and KDM2B,
perhaps reflecting a binding architecture that is disrupted
by modifications on the DNA. Among proteins that showed
specificity for 5mC are previously identified methyl-CpG
binding proteins like MBD4 and RBPJ [20,21], but also
TET1, OGT and interestingly a key pluripotency regulator
ESRRB [22], which has not been previously identified as a
5mC binding protein (Figures 2 and 3). Only few proteins
showed a strong preference for 5hmC (such as RBM14,
PRP8 and RPL26 on Fgf15, MSH6 and PNKP on Pax6
probe, respectively). Similarly to Spruijt et al. [11] we also
did not find MBD3 binding to 5hmC with higher affinity
than to 5mC (as was previously reported by Yildirim et al.
[15]). Instead, MBD3 showed selective binding to 5mC
in the Pax6 target and to 5mC/5fC in the Fgf15 target,
in agreement with Spruijt et al. where MBD3 at high
concentrations had higher affinity to 5mC [11,23]. Our
screen revealed that more proteins bind uniquely to 5fC
than to other DNA modifications (barplots in Figure 1c
and 1d). Notably, 21 proteins were found exclusively bound
to the 5fC probes - 11 on the Fgf15 probe (among which
are TDG, SIX4, ZSCAN21 and ZKSCAN3), 8 on the Pax6
probe (including MPG, FOXP4 and CRSP2) and 2 to
both probes (FOXK2 and FOXI3). Many more proteins
bound to 5fC preferentially (Additional files 1 and 2 and
Figure 4a).
Gene ontology term enrichment comparing modification
specific binders to the full set of identified proteins showed
highly significant groups enriching with relevance to gene
transcription and chromatin regulation among 5fC binders
on the Fgf15 probe (Figure 2b). Association of 5fC with
repressive transcription complexes was a surprising finding
where, notably, all members of the core NuRD complex
were enriched in the group of 5fC specific binding proteins
(Figure 2a), although it is likely that some of the members
of the complex are not direct 5fC binders but are enriched
by secondary protein-protein interactions. This indicates
that 5fC is more likely to be associated with gene repres-
sion. Interestingly, many of the proteins enriched for 5fC
at the Fgf15 probe were enriched for 5mC too, as seen by
the hierarchical clustering, strengthening the potentially
repressive properties of 5fC especially in the context of a
CpG island sequence. This was not the case with the Pax6
probe, which is not a CpG island (Figure 3). It remains
to be seen if the presence of 5fC in CGIs has inhibitory
functions, especially in the process of cell differentiation.
Clustering of proteins enriching on the Pax6 probe did
not result in a similar grouping of 5fC and 5mC enriching
repressive proteins and the GO analysis showed no signifi-
cant enrichment for repressive complexes indicating that
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Figure 1 A mass spectrometry-based method for detection of 5-formylcytosine binding proteins. (a) Schematic representation of the
pull-down method. DNA oligonucleotides corresponding to the promoter regions of the Pax6 (280 bp) and Fgf15 (248 bp) genes were obtained
by PCR with biotinylated primers and using dATP, dGTP. dTTP and either dCTP, dmCTP, dhmCTP or dfCTP. DNA was then incubated with
Streptavidin-linked beads and with nuclear extract from mouse ES cells. Bound fraction was then eluted and analysed by mass spectrometry.
(b) Western blot showing presence of UHRF1 in the protein fraction captured by methylated and hydroxymethylated probes (both Fgf15 and Pax6)
compared to umodified DNA. (c, d) Venn diagrams and histograms showing distribution of significantly enriched proteins binding to differentially
modified Fgf15 probe (CpG: 14; non-CpG: 69, %CpGs: 11.3%) and Pax6 probe (CpG: 8; non-CpG: 44; %CpG: 5.7%) with schematic representation of their
genomic position.
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of a typical CpG island therefore may not result in an
inhibitory transcriptional signal in the presence of 5fC.
While our experimental system made use of a promoter
CpG island (in Fgf15) these insights may also be applicable
to intragenic CpG islands, which can have higher
levels of DNA modifications [24]. The association between5-formylcytosine and transcription has been investigated
recently, resulting in its linkage variously with active or
poised genes [25-27]. Our results potentially reinforce the
idea that depending on context 5fC could have positive or
negative effects on transcription. Nevertheless, some of the
5fC specific proteins were enriched with both DNA probes
and are shown in Figure 4a. This comparison strongly
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Figure 2 (See legend on next page.)
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Figure 2 5-formylcytosine specific binders to Fgf15 probe are enriched for transcription factors and chromatin regulators. (a) Heatmap
representation of the relative protein enrichment on the Fgf15 probe. Spectral count values for each replicate were analysed by testing the
sample groups using a non-parametric Kruskal-Wallis t-test with a P value cutoff of 0.1. For heatmap display, additional filters for the size of
absolute change between group means were applied, and the data for each gene were normalised by subtracting the median value for that gene
across all experiments from the individual values. A cartoon highlights presence of all the component of the main core of the NuRD complex among
the 5fC binders. (b) Functional annotation enrichment analysis performed on 5fC binders using DAVID shows enrichment for transcription
(mainly zinc-binding factors) and chromatin regulators. Results are expressed with their corresponding Benjamini-corrected P value.
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have 5fC binding properties. Gene ontology results for
the other cytosine modifications for the two probes are
included as Additional files 3 and 4.
In order to validate some of these candidate proteins for
5fC binding specificity, we performed ELISA with purified
recombinant proteins and differentially modified Fgf15
probes. His-tagged isoforms of MPG, L3MBTL2 and
ZSCAN21 were expressed in Sf9 insect cells using a
Baculovirus system, and purified by immobilised metal
ion affinity chromatography (IMAC). We found that all
three proteins bound with higher affinity to 5fC compared
to the other modifications on the DNA (Figure 4b). MPG
is one of the proteins common for both DNA targets and
showed a strong binding preference for 5fC. In a recent
study MPG was identified as a 5hmC specific binder but
the data actually show some binding to 5fC as well [11],
and considering different culturing conditions of ES cells
(2i/LIF), post-translational modifications might modulate
the binding of some proteins to their target [28]. Finally,
we considered the possibility that the 5fC binding proteins
might have a role in the excision of 5fC similar to TDG.
We therefore tested this hypothesis by RNAi in ES cells
(Figure 4c, Additional files 5 and 6). While knockdown
of TDG (which is known to excise 5fC and 5caC [29,30])
resulted in increase of 5fC and 5caC (as measured by mass
spectrometry), knockdown of the other candidates had no
effect. We therefore conclude that the majority of 5fC
binding proteins identified in this screen are less likely to
metabolize 5fC, instead they are more likely to recognize
5fC as an epigenetic signal.
The preferential binding of TET1 to both 5mC (more
strongly) and 5hmC, compared to C (Figure 3) was inter-
esting since the CXXC domain of TET1 has been shown
to differ from that of other CXXC domain-containing
proteins, lacking a typical ‘KFGG’ motif found in most
of the family, with some studies showing its inability to
bind DNA [31], and others suggesting that this peculiarity
allows it to bind not only to unmodified and methylated
DNA, but also to hydroxymethylated DNA [32,33]. This
opens the possibility that the binding could be influenced
by sequence context or protein modifications.
It was of particular interest that our screen identified a
higher number of proteins that appear to preferentially bind
to 5fC (Figure 1c,d) rather than to other modifications, anobservation also reported in Spruijit et al. [11]. It is not
immediately intuitive why there should be more proteins
binding to 5fC than to 5hmC. Of course this could depend
on the tissue analysed and there might be more 5hmC
binding proteins in neural cell types, for example, where
the modification is relatively prevalent. Intriguingly, FOXK2
in addition to being a member of the forkhead box tran-
scription factor family has been shown to bind to T:G
mismatches in DNA but no enzymatic activity has been
identified [34]. Another member of this family, FOXP1, a
key transcriptional regulator in B cells and lung develop-
ment was also identified as strong and specific 5fC binder
in our screen. Recent reports have shown that an ES
cell-specific isoform of FOXP1 is implicated in pluripo-
tency regulation in ESCs by stimulating expression of
pluripotency-related genes like Oct4, Nanog and Nr5a2
[35]. FOXP4, also enriched on both 5fC probes, is involved
in development of the lung and is known to form homodi-
mers and heterodimers with FOXP1, and to interact
with NuRD components [36]. FOXK1 is a transcriptional
regulator involved in myogenic regulation [37], while rela-
tively little is known about the function of mouse FOXI3.
Another transcription factor that appears to bind specific-
ally to 5fC in our screen is ZSCAN21, a strong transcrip-
tional activator that plays a role in both male and female
meiosis [38,39]. The final protein in this category of tran-
scriptional regulation linked with DNA repair is MPG,
which is a base excision repair glycosylase known to excise
modified bases resulting from alkylation damage. MPG was
a highly specific binder for 5fC in our screen, while the
human isoform bound strongly to 5fC in a HeLa sample
extract providing an additional layer of confidence (data
not shown); MPG has been identified as a interacting
partner of MBD1 [40] and, intriguingly, its methyl-purine
glycosylase domain structurally resembles the formyl
transferase, C-terminal-like domain (IPR011034).
The last category of 5fC binders makes interesting con-
nections with chromatin regulation through the polycomb
and histone methylation pathways. In addition to the pre-
viously mentioned correlation between 5fC and the NuRD
complex, components of another chromatin regulator
complex, E2F6.com-1, were also identified as 5fC binders.
In addition to MGA and CBX3, we isolated and verified
L3MBTL2 as a 5fC binder, which is a putative polycomb
protein which may bind to modified histones, while
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Iurlaro et al. Genome Biology 2013, 14:R119 Page 6 of 11
http://genomebiology.com/2013/14/10/R119
(See figure on previous page.)
Figure 3 Relative protein enrichment in pull-downs with the Pax6 probe. Heatmap representation of the relative protein enrichment on the
Pax6 probe. Spectral count values for each replicate were analysed by testing the sample groups using a non-parametric Kruskal-Wallis t-test with
a P value cutoff of 0.1. For Heatmap display, additional filters for the size of absolute change between group means were applied, and the data
for each gene were normalised by subtracting the median value for that gene across all experiments from the individual values.
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methylates H3K9 to H3K9me1 and me2, potentially pro-
viding a link between modifications in euchromatin that
are intermediates between transcriptional repression and
activation [41,42].
Conclusions
We have established a relatively simple and robust screen
for proteins that bind 5hmC and 5fC in DNA. 5fC has so0
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Figure 4 Validation and functional analysis of 5fC binding proteins. (a
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fied 5fC-binding proteins with functions in transcription
and in chromatin regulation, particularly involving fork-
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mediate in demethylation and an epigenetic signal in its
own right. The dual potential of some of the proteins we
have identified (FOXK2 in transcription and DNA repair,
EHMT1 mediating between 5fC and H3K9 methylation)
is particularly interesting and warrants future functional
investigations.
Methods
Cell lines and cell culture
E14 ES cells (derived from the E14 cell line strain 129P2/
OlaHsd) were grown on a γ-irradiated pMEF feeder layer
at 37°C and 5% CO2 in complete ES medium (DMEM
4,500 mg l-1 glucose, 4 mM l-glutamine and 110 mg l−1
sodium pyruvate, 15% fetal bovine serum, 100 U of peni-
cillin/100 μg of streptomycin in 100 mL medium, 0.1 mM
non-essential amino acids, 50 μM β-mercaptoethanol, 103
U LIF ESGRO).
Nuclear extraction
Cells were washed with 1× PBS solution, detached adding
trypsin at 37°C to the culture plate and centrifuged at
300 × g for 4 min. The pellet was then washed in ice-cold
1× PBS twice and resuspended gently in 5 volumes of ice-
cold 1 Cytoplasmic Lysis Buffer (Chemicon International®)
containing 0.5 mM DTT and 1/1,000 dilution of supplied
protease inhibitor Cocktail. The solution was incubated
on ice for 15 min, centrifuged at 300 × g for 5 min at 4°C,
and the pellet was resuspended in two volumes of ice-cold
1× Cytoplasmic Lysis Buffer. Cells were lysed using a
27-gauge needle and the nuclear fraction was isolated
from the cytosolic portion by centrifugation at 8,000 × g
for 20 min at 4°C. Finally, the pellet was resuspended in
two-thirds of the original cell pellet volume of ice-cold
Nuclear Extraction Buffer (Chemicon International®) con-
taining 0.5 mM DTT and 1/1,000 dilution of supplied
protease inhibitor cocktail, incubated on orbital shaker
for 60 min at 4°C, and centrifuged at 16,000 × g for
5 min at 4°C. The nuclear extract was then aliquoted
and stored at −80°C.
DNA probes
The probes were obtained by PCR amplification of gen-
omic region corresponding to the promoters of Pax6
(280 bp) and Fgf15 (248 bp) genes using DreamTaq™
DNA Polymerase (Fermentas). The primers used in the
reaction were:
Pax6-F (Biotinylated):
ATTCCCAAAGCAAGCAGAAG
Pax6-R: ACTGTTGACTTTGTGGCCTAGA
Fgf15-F (Biotinylated):
TTTCTTTCAGGCAGGGGAAT
Fgf15-R: TTGAGAAGGGTGGACTGACCPull-down
The pull-down assay was carried out using Dynabeads®
M-280 Streptavidin (Invitrogen™). For each sample, 2 μL
of beads were washed in buffer PBT (1× PBS, 0.1% Triton
X-100), and incubated with 50 ng of biotinylated DNA
in 200 uL of PBS, overnight at 4°C. The beads were then
washed three times in PBT and twice in buffer D-T
(0.2 mM EDTA, 20% Glycerol, 20 mM Hepes-KOH
pH 7.9, 0.1 M KCl, 1 mM DTT, 1 mM protease inhibitor
PMSF, 0.1% Triton X-100), and incubated with 50 μg of
nuclear extract for 15 min at 4°C in incubation buffer
(0.05 mM EDTA, 5% Glycerol, 5 mM Hepes-KOH pH 7.9.
150 mM KCl, 1 mM DTT, 1 mM protease inhibitor PMSF,
0.025% Triton X-100 in PBS). The beads were washed six
times in Buffer D-T, once in PBS and eluted in 1X LDS
Loading buffer boiling at 95°C for 5 min. The eluted
fraction was separated from the beads and finally analysed
by mass spectrometry.
RNAi knockdown of Mpg, Tdg, L3mbtl2, Zscan21, Ehmt1,
FoxK2 and FoxP1 in ES cells
Transfections of Dharmacon siGENOME SMARTpool
against mouse Tdg (catalogue number M-040666-01;
gaagugcaguauacauuug, gaguaaagguuaagaacuu, caaagaag
auggcuguuaa, gcaaggaucugucuaguaa) and siGENOME
ON-TARGETplus siRNA against Mpg (catalogue no. J-
060513-11; ccggcuaggaccagaguuu), L3mbtl2 (catalogue
no. J-065321-12; uuacugacuggaagagcua), FoxP1 (catalogue
no. J-065400-09; gagcaugcgcuggacgaua), Ehmt1 (catalogue
no. J-059041-12; gagcacagguggauccgaa), Zscan21/Zipro1
(catalogue no. J-048225-09; cuagagauaucccguaaga), FoxK2
(catalogue no. J-064514-12; ccagagcucaagcgaguua) were
done with Lipofectamine 2000 according to the manufac-
turer’s instructions. Cells were harvested after three rounds
of transfection for DNA/RNA isolation.
Mass spectrometry
Eluted proteins were run a short distance (approximately
5 mm) into an SDS-PAGE gel, which was then stained
with colloidal Coomassie stain (Imperial Blue, Invitrogen).
The entire stained gel pieces were excised, then destained,
reduced, carbamidomethylated and digested overnight
with trypsin (Promega sequencing grade, 10 ng/μL in
25 mM ammonium bicarbonate) as previously described
[44]. Aliquots of each of the resulting tryptic digests
were analysed by LC-MS/MS on a system comprising a
nanoLC (Proxeon) coupled to a LTQ Orbitrap Velos mass
spectrometer (Thermo). LC separation was achieved on a
reversed-phase column (Reprosil C18AQ, 0.075 × 150 mm,
3 μm particle size), with an acetonitrile gradient (0-35%
over 60 min, containing 0.1% formic acid, at a flow rate of
300 nL/min). The mass spectrometer was operated in
data-dependent acquisition mode, with an acquisition cycle
consisted of a high resolution precursor ion spectrum over
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(with a 60 s dynamic exclusion of former target ions).
Mass spectrometric data were searched against a database
generated from the mammalian entries in Uniprot 2011.09
by concatenation of the forward and reversed sequences,
using Mascot (Matrix Science) and the search results were
processed using Scaffold software (Proteome Software Inc.).
Criteria for protein identification were: minimum of two
peptides, each with a probability of >50% and an overall
protein probability of >99%, which gave a protein false
discovery rate of 0.4%. The mass spectrometry proteomics
data have been deposited to the ProteomeXchange Con-
sortium [45] via the PRIDE partner repository [46] with
the dataset identifier PXD000524.
Western blot
Pulled-down proteins were eluted from beads in LDS
Loading buffer, boiled and run on NuPAGE® Novex 4-12%
Bis-Tris Gel 1.0 mm (Novex®). Proteins were transferred
on a nitrocellulose membrane using iBlot® Blotting System
(Life Technologies), membrane was blocked overnight in
PBS-0.1%Tween (PBST) containing 5% BSA (blocking
buffer). Primary antibody incubation was done at room
temperature for 2 h with a rabbit polyclonal anti-UHRF1
Antibody (Santa Cruz M-132: sc-98817). Membrane was
washed in PBST and incubated with HRP conjugated anti-
rabbit secondary antibody in blocking buffer. HRP conju-
gates were detected with enhanced chemiluminescence
(ECL, Amersham Biosciences).
Enzyme-linked immunosorbent assay (ELISA)
All binding reactions were carried out in buffer Z contain-
ing 20 mM TRIS HCL (pH 7.5), 150 mM NaCl, 20 mM
KCl, 0.02% IGEPAL and 1 mM dithiothreitol. A Highbind
Streptaplate (Roche) was blocked with 1 × PBS containing
3% BSA prior reaction. Subsequently, 50 μL of a 50 nM
solution of biotinylated DNA were added per well and
allowed to attach for 30 min at 37°C with gentle shaking.
Wells were then washed three times with buffer Z. The
proteins were diluted in buffer Z and 50 μL were added to
each well. After incubation for 1 h at room temperature,
plates were washed three times with buffer Z. For detection,
50 μL of mouse polyclonal anti-His tag antibody (Thermo
Scientific) at 1:500 dilution in buffer Z were added per well
and incubated for 1 h at room temperature. After washing
three times with buffer Z, a polyclonal HRP-conjugated
sheep anti-Mouse IgG antibody (GE Healthcare) diluted
1:2,000 in buffer Z was added and incubated for 30 min at
room temperature. Wells were washed three times with
buffer Z and peroxidase activity detected by adding 50 μL
of TACS-Sapphire (Trevigen). Reactions were stopped by
the addition of 50 uL of a 1 M HCL solution. Absorbance at
450 nm was measured using a SPECTROstar Nano (BMG
Labtech). The equilibrium dissociation constants (Kd) forthe protein-DNA interaction were determined by non-
linear regression by fitting to a hyperbolic binding curve.
Purification of recombinant MPG, L3MBTL2 and ZSCAN21
from Baculovirus infected Sf9 cells
Coding sequences for the proteins MPG, L3MBTL2 and
ZSCAN21 (Source BioScience) were cloned into Gateway®
entry vector pENTR223.1 using SfiI restriction sites. CDS
were then cloned into destination vector pDEST10 using
Gateway® LR Clonase II mix (Invitrogen) and following
manufacturer’s instructions. Resulting vectors were used to
transform MAX Efficiency® DH10Bac™ cells (Invitrogen).
Positive clones were selected by blue-complementation and
correct insertion of sequence of interest was confirmed by
PCR. Resulting bacmids were then transfected into Sf9 cells
using Cellfectin® II Reagent (Invitrogen). Baculoviruses
were then amplified and Sf9 cells expressing the proteins
of interest were then harvested at 48, 72 and 96 h post
infection for protein expression analysis. Cells pellets were
resuspended in Lysis Buffer (50 mM NaH2PO4, 300 mM
NaCl, 10 mM imidazole, 1% Triton and protease inhibi-
tors), incubated on ice for 10 min and centrifuged at
10,000 × g for 10 min at 4°C. Cell lysates were filtered
through a 0.2 μm filter and loaded on 1 mL HisTrap HP
column (GE Healthcare) equilibrating with buffer A
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole),
washed with 10 column volumes of buffer A added
with 40 mM imidazole. Proteins were eluted with a
gradient of 40–500 mM imidazole over 20 column vol-
umes. Protein samples were dialysed against storage buffer
(25 mM Tris–HCl pH 7.5 10% glycerol, 150 mM NaCl,
1 mM DTT).
Data analysis
Spectral count values from LC-MS/MS were analysed by
testing the sample groups using a non-parametric Kruskal
Wallis t-test with a P value cutoff of 0.1, which was deter-
mined to be sufficient to identify any group where the most
extreme values all fell within that group, regardless of how
the values were distributed across the other groups.
Gene ontology
Functional annotation enrichment analyses were performed
using The Database for Annotation, Visualization and
Integrated Discovery (DAVID) v6.7 [47-49].
Mass spectrometry of nucleosides
Quantitation of nucleosides in genomic DNA was done
essentially as described previously [27] except that a
Q-Exactive mass spectrometer (Thermo) fitted with an Ul-
tiMate 3000 RSLCnano HPLC (Dionex) was used and one
additional transition 272.1 >156.0404 (caC) was monitored.
Results are expressed as % or ppm of total unmodified and
modified cytosines.
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Additional file 1: Complete pull-down data. Excel file with table
showing all proteins identified by mass spectrometry in the three
replicates, with their corresponding spectral counts. Sheet 1 lists proteins
identified by the Fgf15 probe, sheet 2 lists proteins identified by the Pax6
probe.
Additional file 2: Pull-down data relative to all proteins with
significant enrichment. Excel file with table showing all proteins that
passed the significance test, with their corresponding spectral counts in
the three replicates and P value. Sheet 1 lists proteins identified by the
Fgf15 probe, sheet 2 lists proteins identified by the Pax6 probe.
Additional file 3: DAVID Gene ontology analysis on proteins
enriched for C, 5mC and 5hmC on the Fgf15 probe. Enrichment for
5fC is shown in Figure 2b. Results are expressed with their corresponding
Benjamini-corrected P value.
Additional file 4: DAVID Gene ontology analysis on proteins
enriched for C, 5mC and 5hmC on the Pax6 probe. 5fC binding
proteins showed no significant term enrichment. Results are expressed
with their corresponding Benjamini-corrected P value.
Additional file 5: Knockdown efficiency. Bar plots showing
knockdown efficiency in mESC. Dark grey bars indicate mRNA levels in
the knockdown samples, light grey in the control samples (transfected
with non-targeting siRNA).
Additional file 6: Mass spectrometry of nucleosides data. Excel file
showing mass spectrometry data from the knockdown samples
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